A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease
<p>Abstract</p> <p>Classical non-insulin antihyperglycemic drugs currently approved for the treatment of type 2 diabetes mellitus (T2DM) comprise five groups: biguanides, sulfonylureas, meglitinides, glitazones and alpha-glucosidase inhibitors. Novel compounds are represented by th...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-07-01
|
Series: | Cardiovascular Diabetology |
Online Access: | http://www.cardiab.com/content/8/1/38 |